Drugmaker shares drop after RFK Jr. tapped to lead HHS

By The Hill | Created at 2024-11-15 17:30:08 | Updated at 2024-11-15 19:32:17 2 hours ago

Shares in several pharmaceutical and biotechnology companies have fallen since President-elect Trump announced Thursday that he had tapped vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services (HHS). The SPDR S&P Biotech ETF, which tracks the biotech sector, has dropped 3.7 percent as of noon. Shares in major pharmaceutical…

Read Entire Article